substance p has been researched along with Chronic Disease in 185 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (6.49) | 18.7374 |
| 1990's | 60 (32.43) | 18.2507 |
| 2000's | 73 (39.46) | 29.6817 |
| 2010's | 33 (17.84) | 24.3611 |
| 2020's | 7 (3.78) | 2.80 |
| Authors | Studies |
|---|---|
| Boyvadoglu, C; Inaloz, HS; Korkmaz, P; Ozaydin-Yavuz, G; Taysı, S; Ulusal, H; Yavuz, IH | 1 |
| Metz, M | 1 |
| Duan, XH; Huang, YZ; Liu, WL; Su, KH; Wang, T; Yan, YF; Yang, L | 1 |
| Belzberg, M; Huang, AH; Kwatra, SG; Williams, KA | 1 |
| Boodhoo, K; Myburgh, KH; Tabb, DL; van de Vyver, M; Vlok, M | 1 |
| Eirefelt, S; Hawro, T; Hoey, G; Koopmann, W; Maurer, M; Metz, M; Ohanyan, T; Schoepke, N | 1 |
| He, S; Wang, W; Zhang, H; Zheng, W | 1 |
| Liu, L; Sun, T; Wang, L; Zhang, L | 1 |
| Capizzi, A; Ghezzi, M; Rossi, GA; Sacco, O; Silvestri, M | 1 |
| Doche, I; Ericson, M; Hordinsky, MK; McAdams, BD; Romiti, R; Valente, NS; Wilcox, GL | 1 |
| Arrigo, M; Beauvais, F; Cohen-Solal, A; Launay, JM; Logeart, D; Nougué, H; Pezel, T; Picard, F; Sadoune, M; Vodovar, N | 1 |
| Bumanglag, AV; Burke, SN; Chun, E; Sloviter, RS | 1 |
| Ständer, S; Yosipovitch, G | 1 |
| Asano, T; Fukumitsu, K; Hijikata, H; Kamiya, T; Kanemitsu, Y; Kubota, E; Niimi, A; Suzuki, M; Takeda, N; Takemura, M; Ueda, T; Yamaba, Y | 1 |
| Fayne, RA; Hashimoto, T; Kursewicz, CD; Nanda, S; Nattkemper, L; Shah, SM; Yokozeki, H; Yosipovitch, G | 1 |
| Rees, JD; Scott, A; Stride, M | 1 |
| Dombrowski, F; Heidecke, CD; Kessler, W; Partecke, LI; Schmidt-Wankel, F; Thiele, A; von Bernstorff, W; Wodny, M | 1 |
| Chen, JW; Fu, WQ; Guo, LL; Jiang, Y; Liu, N; Murao, K; Shang, J; Wang, GQ; Wang, LH; Zhang, GX; Zhou, XP | 1 |
| Chun, J; Khan, S; Kim, YS; Shehzad, O | 1 |
| Groffik, A; Hawro, T; Krull, C; Maurer, M; Metz, M; Saluja, R; Stanger, C; Staubach, P | 1 |
| Lotts, T; Ständer, S | 1 |
| Ma, Y; Men, B; Shen, BQ; Sun, ZX; Wang, ZL | 1 |
| Fujisawa, D; Fujitani, Y; Hayama, K; Kashiwakura, J; Kikukawa, Y; Kita, H; Kuroda, K; Nunomura, S; Okayama, Y; Ra, C; Sasaki-Sakamoto, T; Terui, T | 1 |
| Başak, PY; Buyukbayram, HI; Erturan, I; Kazanoglu, OO; Vural, H | 1 |
| Bäckryd, E; Gerdle, B; Ghafouri, B; Ghafouri, N; Karlsson, L; Larsson, B; Olausson, P | 1 |
| Liu, YJ; Song, GH; Zhang, C | 1 |
| Barry, DM; Chen, XJ; Chen, ZF; Li, H; Li, YQ; Liu, XT; Liu, XY; Munanairi, A; Shen, KF; Sun, YG; Wu, ZY; Yin, J | 1 |
| He, S; Wang, J; Xu, C; Zheng, W; Zhu, W | 1 |
| Barrett, KE; Camilleri, M; Sellin, JH | 1 |
| Agelopoulos, K; Loser, K; Lotts, T; Luger, TA; Phan, NQ; Schmaus, G; Ständer, S | 1 |
| Diraman, E; Lütfioğlu, M; Odyakmaz, S; Pamuk, F; Sakallioğlu, EE; Sakallioğlu, U | 1 |
| Altdorfer, K; Fehér, E; Pongor, E; Sipos, G; Sipos, P | 1 |
| da Costa, ED; Paiva, ES; Scheinberg, M | 1 |
| Hattori, N; Miyamoto, N; Mochizuki, H; Tanaka, R; Urabe, T; Zhang, N | 1 |
| Seybold, VS | 1 |
| Coleman, CG; Lessard, A; Pickel, VM | 1 |
| Chen, ZW; Li, LK; Li, WB; Liu, LM; Lu, GS; Pan, JH; Song, B; Xiong, EQ; Yang, Z; Zhang, H; Zhang, JH; Zhou, ZS | 1 |
| Böhm, M; Capellino, S; Haas, S; Luger, TA; Phan, NQ; Ständer, S; Straub, RH | 1 |
| Chung, JW; Chung, SC; Jang, MU; Kho, HS; Park, JW | 1 |
| Alesci, S; Bonne, O; Charney, DS; Collins, C; Gill, JM; Kinkead, B; Luckenbaugh, DA; Manji, HK; Neumeister, A; Owens, MJ; Vythilingam, M; Yuan, P | 1 |
| Chow, CW; Farmer, PJ; Hutson, JM; King, SK; Southwell, BR; Yik, YI | 1 |
| Liu, B; Lü, H; Qiu, Z; Xu, S; Yu, L; Zhao, T | 1 |
| Amiri, M; Beiraghdar, F; Davoudi, SM; Hoseininejad, SL; Kolivand, M; Panahi, Y; Sahebkar, A | 1 |
| El-Nour, H; Grip, L; Holst, M; Johansson, B; Lonne-Rahm, SB; Nordlind, K; Theodorsson, E | 1 |
| Harbuz, MS; Jessop, DS | 1 |
| Erin, N; Eyigor, H; Eyigor, M; Gultekin, M; Osma, U; Yilmaz, MD | 1 |
| Csáti, A; Kuris, A; Lukács, M; Majláth, Z; Szok, D; Tajti, J; Tuka, B; Vécsei, L | 1 |
| Alpar, EK; Killampalli, VV; Onuoha, G; Waters, R | 1 |
| Berghaus, A; Holzhausen, HJ; Knipping, S; Mir Salim, PA | 1 |
| Bodfish, JW; Sutton, KA; Symons, FJ; Walker, C | 1 |
| Liu, HX | 1 |
| Lu, Y; Vera-Portocarrero, LP; Westlund, KN | 1 |
| Corcoran, BM; Mayhew, IG; Prince, D | 1 |
| Iadarola, MJ; Lonser, RR; Morrison, PF; Sarntinoranont, M | 1 |
| El-Salhy, M | 1 |
| Actor, JK; Chappell, CL; Lewis, DE; Okhuysen, PC; Robinson, P; Weinstock, JV; White, AC | 1 |
| Boncz, I; Csillik, B; Janka, Z; Kálmán, J; Knyihár, E; Mihály, A; Vécsei, L | 1 |
| Arsenescu, R; Blum, A; Bunnett, N; Elliott, D; Metwali, A; Weinstock, JV | 1 |
| Depaulis, A; Fernandes, GA; Levy, S; Namer, IJ; Ruocco, HH | 1 |
| Cho, YS; Lee, CK; Moon, HB; Park, SY; Yoo, B | 1 |
| Fang, MR; Huang, ZJ; Lin, M; Pang, ZJ; Wu, JS; Yan, HD; Zhou, JF | 1 |
| Weinstock, JV | 1 |
| Alaçam, T; Oral, B; Tuncer, LI | 1 |
| Chen, JG; Guan, BC; Li, ZW; Liu, CJ; Wu, ZZ; Yang, Q | 1 |
| Catto-Smith, T; Chase, J; Djaja, S; Farmer, P; Gibb, S; Hutson, JM; King, S; Ong, SY; Shin, YM; Southwell, B; Stanton, M; Sutcliffe, J | 1 |
| Arcari, ML; Ballabeni, V; Barocelli, E; Bertoni, S; Gabella, G; Ghizzardi, P; Impicciatore, M; Lagrasta, C | 1 |
| Nakano, Y | 1 |
| Gao, H; Han, D; Peng, S; Zhang, H; Zhu, X | 1 |
| Hayashida, Y; Hirakawa, H; Kawakami, T; Kusakabe, T; Matsuda, H; Oikawa, S; Takenaka, T | 1 |
| Bartfai, T; Fetissov, S; Gaudet, L; Hökfelt, T; Jimenez, PA; Mathé, AA; Moreau, JL; Mortas, P; Sergeyev, V | 1 |
| Asero, R; Lorini, M; Tedeschi, A | 1 |
| Riley, G | 1 |
| El-Raziky, M; El-Raziky, MS; Gohar, N | 1 |
| He, ZJ; Pasricha, PJ; Shenoy, M; Winston, JH; Xiao, SY | 1 |
| Kreider, RA; Rothman, SM; Winkelstein, BA | 1 |
| Toru, M | 1 |
| Hayashida, Y; Hirakawa, H; Kusakabe, T; Matsuda, H; Oikawa, S | 2 |
| Gutkin, DW; Pezzone, MA; Ustinova, EE | 1 |
| Dickenson, AH; Hunt, S; Rahman, W; Rygh, LJ; Sandhu, H; Suzuki, R; Vonsy, JL; Webber, M; Wong, Y | 1 |
| Fabry, Z; Johnson, MJ; Karman, J; Lee, J; Ling, C; Reinke, EK; Sandor, M; Weinstock, JV | 1 |
| Al-Mutawaly, N; Bercik, P; Blennerhassett, PA; Collins, SM; Ghia, JE; Verdu, EF; Verma-Gandhu, M | 1 |
| Bady, P; Baumann, T; Bigliardi, PL; Bigliardi-Qi, M; Gaveriaux-Ruff, C; Kieffer, BL; Pfaltz, K; Rufli, T | 1 |
| Dömötör, A; Hunyady, B; Kereskay, L; Mózsik, G; Szekeres, G; Szolcsányi, J | 1 |
| Lonne-Rahm, S; Nordlind, K; Remröd, C | 1 |
| Song, B; Zhang, SW; Zhou, ZS | 1 |
| Alfredson, H; Andersson, G; Danielson, P; Forsgren, S | 1 |
| Bianchi, M; Ferrario, P; Franchi, S; Sacerdote, P; Sotgiu, ML | 1 |
| Peterson, EL | 1 |
| Rosenkranz, MA | 1 |
| Jang, JE; Jung, JS; Kwon, MS; Lee, JK; Park, SH; Seo, YJ; Shim, EJ; Suh, HW | 1 |
| Kozlova, IV; Volkov, SV | 1 |
| Akcali, C; Aynacioglu, AS; Benlier, N; Erbagci, Z; Ozkur, M | 1 |
| Jiang, SH; Lou, XF; Pang, LX; Shi, XM; Tu, WZ; Yang, GH; Zhang, RF | 1 |
| Kenyon, JN; Lewith, GT | 1 |
| Albuquerque, RH; Bannister, R; Barnes, AJ; Bishop, AE; Bloom, SR; Long, RG; McGregor, GP; O'Shaughnessy, DJ; Polak, JM | 1 |
| Boni, B; Casacchia, M; Cerbo, R; Corona, R | 1 |
| Fields, HL; Levine, JD | 1 |
| Chowdrey, HS; Harbuz, MS; Jessop, DS; Larsen, PJ; Lightman, SL | 1 |
| Hayrinen-Immonen, RH; Hukkanen, M; Konttinen, YT; Malmstrom, MJ; Nordstrom, D; Polak, J; Sorsa, T | 1 |
| Alvarez, C; Brecha, NC; De Giorgio, R; Go, VL; Reber, HA; Sternini, C; Widdison, AL | 1 |
| Boudouresque, F; Giraud, P; Guieu, R; Tardy-Gervet, MF | 1 |
| Archer, SL; Hampl, V; Isaacson, TC; Nelson, DP; Weir, EK | 1 |
| Hersh, EV; Ochs, HA; Pertes, RA | 1 |
| Besson, JM; Calvino, B; Couraud, JY | 1 |
| Hirayama, Y; Ichinose, M; Miura, M; Nakajima, N; Shirato, K; Tomaki, M; Yamauchi, H | 1 |
| Chen, CF; Chien, CT; Lai, YL; Shiao, HL; Thacker, AA; Zhang, HQ | 1 |
| Luts, A; Pilmane, M; Sundler, F | 1 |
| Cornefjord, M; Farley, DB; Olmarker, K; Rydevik, B; Weinstein, JN | 1 |
| Chiarenza, AP; Elverdin, JC; Frid, AB; Giglio, MJ | 1 |
| Qiao, J; Tao, Z; Xiao, J; Zhao, C; Zhao, S | 1 |
| Goldin, E; Karmeli, F; Lysy, J | 1 |
| Giraud, P; Guieu, R; Tardy-Gervet, MF | 1 |
| Johnson, BW; Kambam, JR; Naukam, RJ; Parris, WC; Sastry, BV | 1 |
| Blackwell, JM; Chowdrey, HS; Harbuz, MS; Jessop, DS; Larsen, PJ; Lightman, SL | 1 |
| Killingsworth, CR; Paulauskis, JD; Shore, SA | 1 |
| Kajander, KC; Pollock, CH; Xu, J | 1 |
| Carney, AS; Jones, NS | 1 |
| Gingras, JL; Long, WA; Segreti, T; Wasserstein, M | 1 |
| Hutson, JM | 1 |
| Aloe, L; Angelucci, F; Fiore, M; Moroni, R | 1 |
| Dalmaz, Y; Denoroy, L; Jouvet, M; Pequignot, JM; Poncet, L | 1 |
| Rees, S; Tolcos, M | 1 |
| Ellisman, MH; Kawakami, T; Kusakabe, T; Powell, FL; Sawada, H; Takenaka, T | 1 |
| Didion, SP; Mayhan, WG | 1 |
| Catto-Smith, AG; Chow, CW; Hurley, MR; Hutson, JM; Uemura, S; Wheatley, JM | 1 |
| Chen, CF; Chen, LW; Chien, CT; Wu, MS | 1 |
| Carlsöö, B; Lidegran, M; Midvedt, T; Nilsson, L; Norlander, T; Rivero, C; Stierna, P | 1 |
| Caramori, G; Ciaccia, A; Fabbri, L; Facchini, F; Lucchini, RE; Maestrelli, P; Mapp, CE; Polak, JM; Saetta, M; Springall, DR; Turato, G | 1 |
| Brodin, E; Delander, GE; Fredholm, BB; Schött, E | 1 |
| Figueroa, JM; Mansilla, E; Suburo, AM | 1 |
| Lai, LC; Lai, YL; Lin, CW | 1 |
| Franke, S; Hein, G; Kluge, H; Sprott, H | 1 |
| Adler, G; Ernst, S; Eysselein, VE; Flämig, G; Geerling, I; Reinshagen, M; Walsh, JH; Wong, H | 1 |
| Bousquet, J; Chanez, P; Godard, P; Moradoghi-Hattvani, A; Polak, JM; Springall, D; Vignola, AM | 1 |
| Luo, F | 1 |
| Baluk, P; Lindsey, JR; McDonald, DM; Murphy, TJ; Thurston, G | 1 |
| Chen, CF; Lai, YL; Wu, HD | 1 |
| Hoheisel, U; Kaske, A; Mense, S | 1 |
| Altomare, DF; Genualdo, M; Mansi, G; Memeo, V; Mitolo, CI; Mitolo-Chieppa, D; Montagnani, M; Potenza, MA; Rinaldi, M; Rinaldi, R; Serio, M | 1 |
| Helme, RD; Khalil, Z; Liu, T | 1 |
| Benoliel, R; Caudle, RM; Eliav, E; Iadarola, MJ; Leeman, S; Mannes, AJ | 1 |
| Borici-Mazi, R; Kontou-Fili, K; Kouridakis, S | 1 |
| Calvino, B; Grannec, G; Onténiente, B; Pezet, S | 1 |
| Basbaum, AI | 1 |
| Andersson, B; Gillquist, J; Messner, K; Räsänen, T; Wei, Y | 1 |
| de Souza, RR; Liberti, EA; Maifrino, LB | 1 |
| Friedrich, MJ | 1 |
| Hayashida, Y; Kawakami, T; Kusakabe, T; Matsuda, H; Takenaka, T | 1 |
| Baccante, G; Büchler, MW; Di Febbo, C; di Mola, FF; Di Sebastiano, P; Friess, H; Innocenti, P; Porreca, E | 1 |
| Rau, CL; Russell, IJ | 1 |
| Hietanen, J; Hukkanen, M; Konttinen, YT; Malmström, M; Nissalo, S; Polak, J | 1 |
| Jüsten, HP; Miller, LE; Schölmerich, J; Straub, RH | 1 |
| Kaneko, M; Kawakita, T; Kuraishi, Y; Maekawa, T; Miyamoto, T; Nishikawa, Y; Nojima, H; Yamaguchi, T | 1 |
| Baluk, P; Gómez, AD; Hashizume, H; Kwan, ML; McDonald, DM | 1 |
| Echizen, H; Fukatsu, T; Hashiguchi, M; Itoh, T; Kariya, S; Nishimura, E; Odanaka, J; Ohtani, M; Okumura, H; Rikihisa, T; Takahashi, T; Uchino, K; Watanabe, K | 1 |
| Yonehara, N; Yoshimura, M | 1 |
| Goldin, E; Granot, E; Karmeli, F; Lysy, J; Waldbaum, C; Wengrower, D | 1 |
| Corbett, AD; McKee, R; Menzies, JR | 1 |
| Alberti, A; Floridi, A; Gallai, V; Sarchielli, P | 1 |
| Boulos, P; Davis MSc, C; Gabella, G; Herrick, SE; Laurent, GJ; Mutsaers, SE; Sulaiman, H | 1 |
| Kastin, AJ; Martin-Schild, S; Smith, RR; Zadina, JE | 1 |
| Abrams, GA; Bentley, E; Campbell, S; Marfurt, CF; McDermott, A; Murphy, CJ; Reid, TW | 1 |
| Chen, S; Song, Z; Wu, J; Zhang, J | 1 |
| Chen, CF; Chu, SJ; Lai, YL; Ma, MC | 1 |
| Brakch, N; Cavadas, C; Giger, R; Grouzmann, E; Lacroix, JS; Landis, B; Malis, D; Monod, M; Morel, DR; Nicoucar, K; Szalay-Quinodoz, I; Wilk, S | 1 |
| Chen, CF; Chien, CT; Huang, HS; Ma, MC; Wu, MS | 1 |
| Aanonsen, LM; Bennett, GJ; Kajander, KC; Seybold, VS | 1 |
| Cimitan, A; Fantini, F; Giannetti, A; Pincelli, C | 1 |
| Atkinson, B; Foreman, JC; Hayes, N; Lee, TH; Morris, RW; Smith, CH | 1 |
| Beger, HG; Bockman, E; Büchler, M; Friess, H; Malfertheiner, P; Müller, S; Nohr, D; Weihe, E | 1 |
| Holmdahl, R; Nyberg, F; Persson, S; Post, C | 1 |
| Aldskogius, H; Kinnman, E | 1 |
| Butovskaia, ML; Deriagina, MA; Startsev, VG | 1 |
| Zhang, ZB | 1 |
| Albe-Fessard, D; Iwayama, K; Kurihara, M; Mori, K; Niwa, M; Tasker, RR; Yamashiro, K | 1 |
| Molina, E | 1 |
| Almay, BG; Johansson, F; Sakurada, T; Terenius, L; von Knorring, L | 1 |
| Brodin, E; Linderoth, B; Meyerson, BA | 1 |
| Carney, JA; Go, L; Go, VL; Koch, TR | 1 |
| Hunt, S; Wells, C; Williams, S | 1 |
| Almay, BGL; Johansson, F; Le Grevés, P; Terenius, L; Von Knorring, L | 1 |
| Butolin, EG; Danilov, GE; Ibatov, AD; Isakov, LS | 1 |
| Adrian, TE; Bloom, SR; Domschke, S; Domschke, W; Lux, G | 1 |
| Goldin, E; Karmeli, F; Rachmilewitz, D; Selinger, Z | 1 |
21 review(s) available for substance p and Chronic Disease
| Article | Year |
|---|---|
Prurigo nodularis: Pathogenesis and management.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents; Antipruritics; Biopsy; Calcitonin Gene-Related Peptide; Chronic Disease; Diagnosis, Differential; Humans; Immunosuppressive Agents; Medical History Taking; Nerve Tissue Proteins; Neural Pathways; Phototherapy; Prurigo; Randomized Controlled Trials as Topic; Receptors, Nerve Growth Factor; Severity of Illness Index; Skin; Substance P; Therapies, Investigational; Treatment Outcome | 2020 |
Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.
Topics: Animals; Chronic Disease; Clinical Trials, Phase II as Topic; Disease Models, Animal; Humans; Molecular Targeted Therapy; Neurokinin-1 Receptor Antagonists; Pruritus; Quality of Life; Receptors, Neurokinin-1; Severity of Illness Index; Signal Transduction; Skin; Substance P; Treatment Outcome | 2019 |
Tendons--time to revisit inflammation.
Topics: Anti-Inflammatory Agents; Chronic Disease; Cyclooxygenase 1; Cyclooxygenase 2; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Musculoskeletal Pain; Neovascularization, Pathologic; Substance P; Tendinopathy; Tendons; Tumor Necrosis Factor-alpha | 2014 |
Research in practice: substance P antagonism in chronic pruritus.
Topics: Anti-Inflammatory Agents; Chronic Disease; Cytokines; Dermatologic Agents; Evidence-Based Medicine; Humans; Models, Immunological; Pruritus; Skin; Substance P | 2014 |
Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.
Topics: C-Reactive Protein; Chromogranins; Chronic Disease; Diarrhea; Feces; Gastrointestinal Motility; Humans; Inflammation; Intestinal Absorption; Intestinal Mucosa; Intestinal Secretions; Intestines; Irritable Bowel Syndrome; Lactoferrin; Leukocyte L1 Antigen Complex; Osmolar Concentration; Permeability; Prostaglandins; Serotonin; Substance P | 2017 |
Fibromyalgia: an update and immunological aspects.
Topics: Antibodies; Autoantibodies; Chronic Disease; Evoked Potentials, Somatosensory; Fibromyalgia; Headache; Humans; Interleukin-2; Neural Pathways; Nociceptors; Pain Threshold; Polymers; Posterior Horn Cells; Psychophysiologic Disorders; Substance P | 2008 |
The role of peptides in central sensitization.
Topics: Afferent Pathways; Animals; Calcitonin Gene-Related Peptide; Central Nervous System; Chronic Disease; Gene Expression Regulation; Humans; Hyperalgesia; Ligands; Neurons; Pain; Pain Threshold; Receptors, Calcitonin Gene-Related Peptide; Receptors, Neurokinin-1; Substance P; Synaptic Transmission; Transcription Factors | 2009 |
Stress and inflammatory disease: widening roles for serotonin and substance P.
Topics: Acute Disease; Animals; Chronic Disease; Humans; Hypothalamo-Hypophyseal System; Inflammation; Inflammation Mediators; Pituitary-Adrenal System; Serotonin; Stress, Physiological; Stress, Psychological; Substance P | 2001 |
[Botulinum neurotoxin--a therapy in migraine].
Topics: Acute Disease; Analgesics; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Chronic Disease; Clinical Trials, Phase III as Topic; Glutamic Acid; Humans; Migraine Disorders; SNARE Proteins; Substance P; Synaptosomal-Associated Protein 25; Treatment Outcome | 2012 |
The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses.
Topics: Animals; Chronic Disease; Gastroenteritis; Granuloma; Hepatitis; Humans; Immunity, Mucosal; Inflammation; Inflammatory Bowel Diseases; Mice; Protein Precursors; Receptors, Neurokinin-1; Substance P; Tachykinins | 2004 |
Chronic constipation: no longer stuck! Characterization of colonic dysmotility as a new disorder in children.
Topics: Adult; Child, Preschool; Chronic Disease; Colectomy; Colon; Colostomy; Constipation; Electric Stimulation Therapy; Enema; Female; Gastrointestinal Motility; Humans; Infant; Male; Manometry; Monitoring, Ambulatory; Multiple Endocrine Neoplasia Type 2b; Neurons; Nitric Oxide Synthase; Proto-Oncogene Proteins c-kit; Substance P; Vasoactive Intestinal Peptide | 2004 |
Chronic tendon pathology: molecular basis and therapeutic implications.
Topics: Aging; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Collagen; Cumulative Trauma Disorders; Extracellular Matrix; Glycoproteins; Humans; Matrix Metalloproteinases; Middle Aged; Neuropeptides; Proteoglycans; Rupture; Substance P; Tendinopathy; Tendon Injuries; Tendons | 2005 |
[Brain of patients with chronic schizophrenia and neurotransmitters].
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Chronic Disease; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Humans; Neurotransmitter Agents; Receptors, Dopamine D2; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Substance P; Tyrosine 3-Monooxygenase | 2005 |
Fibromyalgia--management of a misunderstood disorder.
Topics: Anticonvulsants; Antidepressive Agents; Causality; Chronic Disease; Diagnosis, Differential; Exercise; Fibromyalgia; Humans; Hypothalamo-Hypophyseal System; Medical History Taking; Neuromuscular Agents; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Care Planning; Patient Education as Topic; Physical Examination; Pituitary-Adrenal System; Primary Health Care; Serotonin; Social Support; Substance P; United States | 2007 |
Substance P at the nexus of mind and body in chronic inflammation and affective disorders.
Topics: Adrenal Medulla; Asthma; Chronic Disease; Humans; Hypothalamo-Hypophyseal System; Inflammation; Mood Disorders; Pituitary-Adrenal System; Psychophysiology; Substance P | 2007 |
Physiological and psychological explanations for the mechanism of acupuncture as a treatment for chronic pain.
Topics: Acupuncture Therapy; Animals; Chronic Disease; Electric Stimulation Therapy; Endorphins; Humans; Hypnosis; Nervous System; Pain; Pain Management; Periaqueductal Gray; Placebos; Raphe Nuclei; Rats; Reflex; Substance P; Thalamus | 1984 |
Pain--mechanics and management.
Topics: Analgesics, Opioid; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Arachidonic Acids; Autonomic Nervous System; Chronic Disease; Humans; Neurons, Afferent; Nociceptors; Pain; Pain Management; Psychotropic Drugs; Sensory Thresholds; Substance P; Sympatholytics; Transcutaneous Electric Nerve Stimulation | 1984 |
Topical capsaicin-pharmacology and potential role in the treatment of temporomandibular pain.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Chronic Disease; Facial Pain; Humans; Nerve Fibers; Substance P; Temporomandibular Joint Disorders | 1994 |
Idiopathic rhinitis: idiopathic or not?
Topics: Air Pollution; Asthma; Chronic Disease; Eosinophilia; Eosinophils; Humans; Immunoglobulin E; Immunoglobulin G; Interleukin-3; Interleukin-4; Rhinitis; Substance P | 1996 |
Distinct neurochemical features of acute and persistent pain.
Topics: Acute Disease; Animals; Chronic Disease; Humans; Isoenzymes; Mice; Mice, Knockout; Neurochemistry; Neurokinin A; Pain; Protein Kinase C; Protein Precursors; Substance P; Tachykinins | 1999 |
Is fibromyalgia a distinct clinical syndrome?
Topics: Autonomic Nervous System; Chronic Disease; Demography; Fibromyalgia; Humans; Neurologic Examination; Neurosecretory Systems; Nociceptors; Pain; Pain Threshold; Spinal Cord; Substance P | 2000 |
4 trial(s) available for substance p and Chronic Disease
| Article | Year |
|---|---|
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.
Topics: Administration, Cutaneous; Aged; Aprepitant; Case-Control Studies; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Neurokinin-1 Receptor Antagonists; Proof of Concept Study; Prospective Studies; Prurigo; Pruritus; Receptors, Neurokinin-1; Severity of Illness Index; Substance P; Visual Analog Scale | 2018 |
Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Antioxidants; Antipruritics; Chemical Warfare Agents; Chronic Disease; Curcumin; Dietary Supplements; Double-Blind Method; Humans; Iran; Irritants; Male; Middle Aged; Mustard Gas; Oxidoreductases; Pruritus; Quality of Life; Severity of Illness Index; Substance P; Surveys and Questionnaires; Veterans | 2012 |
Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: the effect of cetirizine and dimethindene.
Topics: Adult; Calcitonin Gene-Related Peptide; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Hypersensitivity, Delayed; Male; Skin Physiological Phenomena; Substance P; Urticaria | 1999 |
Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticaria.
Topics: Adult; Calcitonin Gene-Related Peptide; Chronic Disease; Female; Humans; Intradermal Tests; Male; Microcirculation; Middle Aged; Neurokinin A; Skin; Substance P; Urticaria; Vasoactive Intestinal Peptide | 1992 |
160 other study(ies) available for substance p and Chronic Disease
| Article | Year |
|---|---|
Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria.
Topics: Anti-Allergic Agents; Calcitonin Gene-Related Peptide; Chronic Disease; Chronic Urticaria; Humans; Immunoglobulin E; Interleukins; Neuropeptide Y; Omalizumab; Substance P; Treatment Outcome; Urticaria | 2023 |
Are we facing a change in the treatment of chronic pruritus?
Topics: Chronic Disease; Humans; Pruritus; Receptors, Neurokinin-1; Substance P | 2019 |
Effects of Zuojin pill on depressive behavior and gastrointestinal function in rats with chronic unpredictable mild stress: Role of the brain-gut axis.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Brain; Chronic Disease; Cytokines; Depression; Drugs, Chinese Herbal; Gastrins; Gastrointestinal Transit; Glucagon-Like Peptide 1; Intestine, Small; Male; Motilin; Rats, Sprague-Dawley; Stress, Psychological; Substance P; Vasoactive Intestinal Peptide | 2020 |
Dysregulated healing responses in diabetic wounds occur in the early stages postinjury.
Topics: Animals; Body Fluids; Chronic Disease; Cytokines; Diabetes Mellitus, Experimental; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Obese; Proteome; Substance P; Wound Healing; Wounds and Injuries | 2021 |
[Up-regulated expression of NK1R in eosinophil-enriched blood cells from patients with chronic spontaneous urticaria].
Topics: Adult; Animals; Chronic Disease; Eosinophilia; Female; Humans; Male; Middle Aged; Neurokinin-1 Receptor Antagonists; Pollen; Pyroglyphidae; Receptors, Neurokinin-1; Substance P; Up-Regulation; Urticaria | 2017 |
The research of the possible mechanism and the treatment for capsaicin-induced cough.
Topics: Animals; Antitussive Agents; Calcitonin Gene-Related Peptide; Capsaicin; Chronic Disease; Codeine; Cough; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Guinea Pigs; Male; Neurokinin A; Pyrrolidines; Substance P; TRPV Cation Channels; Urea | 2018 |
Airway inflammation and injury in children with prevalent weakly acidic gastroesophageal refluxes.
Topics: Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Child, Preschool; Chronic Disease; Female; Gastroesophageal Reflux; Humans; Infant; Inflammation; Macrophages; Male; Pepsin A; Recurrence; Respiratory System; Respiratory Tract Diseases; Retrospective Studies; Substance P | 2018 |
Evidence for neurogenic inflammation in lichen planopilaris and frontal fibrosing alopecia pathogenic mechanism.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Biopsy; Calcitonin Gene-Related Peptide; Chronic Disease; Epidermis; Female; Humans; Immunohistochemistry; Inflammation; Lichen Planus; Lipid Metabolism; Lymphocytes; Male; Microscopy, Confocal; Middle Aged; Neurogenic Inflammation; Neuropeptides; Scalp; Scalp Dermatoses; Substance P | 2020 |
Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Biphenyl Compounds; CD146 Antigen; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Echocardiography; Female; Fructosamine; Glucagon-Like Peptide 1; Heart Failure; Humans; Interleukin-1 Receptor-Like 1 Protein; Male; Middle Aged; Natriuretic Peptide, Brain; Neprilysin; Peptide Fragments; Substance P; Tetrazoles; Treatment Outcome; Troponin I; Valsartan | 2019 |
Targeted hippocampal GABA neuron ablation by Stable Substance P-saporin causes hippocampal sclerosis and chronic epilepsy in rats.
Topics: Animals; Chronic Disease; Dentate Gyrus; Epilepsy, Temporal Lobe; GABAergic Neurons; gamma-Aminobutyric Acid; Hippocampus; Male; Parvalbumins; Rats; Rats, Sprague-Dawley; Saporins; Sclerosis; Substance P | 2019 |
Effect of anti-reflux treatment on gastroesophageal reflux-associated chronic cough: Implications of neurogenic and neutrophilic inflammation.
Topics: Adult; Aged; Chronic Disease; Cough; Female; Gastroesophageal Reflux; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Neutrophils; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Severity of Illness Index; Sputum; Substance P; Treatment Outcome; Visual Analog Scale | 2020 |
Pathophysiologic mechanisms of itch in bullous pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Basophils; Cell Adhesion Molecules; Chronic Disease; Cytokines; Eosinophils; Female; Fluorescent Antibody Technique; Humans; Interleukin-13; Male; Middle Aged; Oncostatin M Receptor beta Subunit; Pemphigoid, Bullous; Pruritus; Receptors, Interleukin; Receptors, Neurokinin-1; Severity of Illness Index; Skin; Substance P; Th2 Cells | 2020 |
Appendicopathy--a clinical and diagnostic dilemma.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendectomy; Appendicitis; Appendix; Child; Chronic Disease; Female; Humans; Immunohistochemistry; Laparoscopy; Male; Middle Aged; S100 Proteins; Substance P; Vasoactive Intestinal Peptide; Young Adult | 2013 |
Chronic restraint stress inhibits hair growth via substance P mediated by reactive oxygen species in mice.
Topics: Animals; Antioxidants; Chronic Disease; Corticosterone; Dermis; Glutathione Peroxidase; Hair; Hair Follicle; Male; Mast Cells; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Oxidative Stress; Reactive Oxygen Species; Receptors, Neurokinin-1; Restraint, Physical; Stress, Psychological; Substance P; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Weight Gain | 2013 |
Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, MAPKs and CREB signaling cascades.
Topics: Acute Disease; Adenosine Triphosphate; Analgesics; Animals; Chronic Disease; Coumarins; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hyperalgesia; Inflammation; Liver; Male; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Pain; Signal Transduction; Substance P; Time Factors; Tumor Necrosis Factor-alpha | 2013 |
Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.
Topics: Anxiety; Biomarkers; Chronic Disease; Depression; Disease Progression; Germany; Humans; Quality of Life; Severity of Illness Index; Substance P; Up-Regulation; Urticaria | 2014 |
[Common TCM syndrome pattern of chronic pelvic pain syndrome relates to plasma substance p and beta endorphin].
Topics: beta-Endorphin; Case-Control Studies; Chronic Disease; Humans; Male; Medicine, Chinese Traditional; Pelvic Pain; Prostatitis; Substance P; Syndrome | 2014 |
Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria.
Topics: Adult; Aged; Aged, 80 and over; Cells, Cultured; Chronic Disease; Eosinophil Granule Proteins; Female; Humans; Male; Mast Cells; Middle Aged; Molecular Targeted Therapy; Nerve Tissue Proteins; Protein Binding; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Skin; Skin Tests; Substance P; Up-Regulation; Urticaria; Vasoactive Intestinal Peptide; Young Adult | 2014 |
Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria.
Topics: Adolescent; Adult; Calcitonin Gene-Related Peptide; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Nerve Growth Factor; Neuropeptide Y; Neuropeptides; Stem Cell Factor; Substance P; Urticaria; Vasoactive Intestinal Peptide; Young Adult | 2014 |
Intramuscular pain modulatory substances before and after exercise in women with chronic neck pain.
Topics: Adult; beta-Endorphin; Chronic Disease; Exercise Therapy; Female; Glutamic Acid; Humans; Hydrocortisone; Lactic Acid; Microdialysis; Middle Aged; Neck Pain; Pain Measurement; Pain Threshold; Pyruvic Acid; Shoulder Pain; Substance P; Superficial Back Muscles; Young Adult | 2015 |
[Prostatic inflammation-induced chronic pelvic pain: Roles of substance P and c-fos in the spinal cord].
Topics: Animals; Chronic Disease; Immunohistochemistry; Male; Pelvic Pain; Prostate; Prostatitis; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Spinal Cord; Substance P; Syndrome; Up-Regulation | 2015 |
Critical evaluation of the expression of gastrin-releasing peptide in dorsal root ganglia and spinal cord.
Topics: Amino Acid Sequence; Animals; Antibody Specificity; Cell Count; Cells, Cultured; Chronic Disease; Ganglia, Spinal; Gastrin-Releasing Peptide; Gene Deletion; Gene Expression Regulation; Male; Mice, Inbred C57BL; Mice, Knockout; Posterior Horn Cells; Pruritus; Receptors, Bombesin; RNA, Messenger; Spinal Cord; Substance P | 2016 |
Upregulated expression of substance P in basophils of the patients with chronic spontaneous urticaria: induction of histamine release and basophil accumulation by substance P.
Topics: Adolescent; Adult; Animals; Antibodies, Anti-Idiotypic; Basophils; Case-Control Studies; Chronic Disease; Female; Histamine Release; Humans; Leukocyte Count; Male; Mice; Middle Aged; Receptors, Neurokinin-1; Substance P; Transcriptional Activation; Up-Regulation; Urticaria; Young Adult | 2016 |
Dihydroavenanthramide D inhibits mast cell degranulation and exhibits anti-inflammatory effects through the activation of neurokinin-1 receptor.
Topics: Animals; Calcium Signaling; Cell Line; Chronic Disease; Drug Evaluation, Preclinical; Humans; Mast Cells; ortho-Aminobenzoates; Pruritus; Rats; Receptors, Neurokinin-1; Substance P | 2017 |
Local peptidergic innervation of gingiva in smoking and non-smoking periodontitis patients.
Topics: Adult; Alveolar Bone Loss; Biopsy; Calcitonin Gene-Related Peptide; Chronic Disease; Dental Plaque Index; Female; Gingiva; Gingival Hemorrhage; Humans; Inflammation Mediators; Male; Middle Aged; Neurogenic Inflammation; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Smoking; Substance P | 2008 |
Correlation and immunolocalization of substance P nerve fibers and activated immune cells in human chronic gastritis.
Topics: Antibody Specificity; Chronic Disease; Gastric Mucosa; Gastritis; Humans; Immunoassay; Microscopy, Confocal; Nerve Fibers; NF-kappa B; Poly(ADP-ribose) Polymerases; Stomach; Substance P | 2008 |
Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model.
Topics: Animals; Bacteria; Carotid Stenosis; Chronic Disease; Cilostazol; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Deglutition; Disease Models, Animal; Dopamine; Enzyme Activation; Fibrinolytic Agents; Gene Expression Regulation; Ligation; Male; Pneumonia; Rats; Rats, Wistar; Regional Blood Flow; Substance P; Substantia Nigra; Tetrazoles; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
Chronic intermittent hypoxia reduces neurokinin-1 (NK(1)) receptor density in small dendrites of non-catecholaminergic neurons in mouse nucleus tractus solitarius.
Topics: Animals; Catecholamines; Chronic Disease; Dendrites; Fluorescent Antibody Technique; Hypoxia, Brain; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microscopy, Immunoelectron; Neuronal Plasticity; Neurons; Receptors, Neurokinin-1; Reflex; Respiratory Mechanics; Sleep Apnea Syndromes; Solitary Nucleus; Substance P; Sympathetic Nervous System; Trigeminal Nucleus, Spinal; Tyrosine 3-Monooxygenase | 2010 |
[Correlation between activation of L5-S2 spinal cord astrocytes and effect of substance P in chronic prostatitis pain].
Topics: Animals; Astrocytes; Chronic Disease; Male; Nitric Oxide Synthase Type II; Pain; Prostatitis; Rats; Receptors, Neurokinin-1; Spinal Cord; Substance P | 2009 |
Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
Topics: Adrenergic Fibers; Adult; Aged; Aged, 80 and over; Biopsy; Chronic Disease; Dermatitis, Atopic; Dermis; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Prurigo; Pruritus; Sensory Receptor Cells; Substance P | 2010 |
Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients.
Topics: Adult; Calcitonin Gene-Related Peptide; Case-Control Studies; Chronic Disease; Facial Pain; Female; Humans; Male; Migraine Disorders; Nerve Growth Factor; Neuropeptides; Pain Measurement; Saliva; Salivary Proteins and Peptides; Secretory Rate; Sex Factors; Substance P | 2011 |
Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Chronic Disease; Corticotropin-Releasing Hormone; Female; Humans; Insulin-Like Growth Factor I; Interleukin-6; Male; Middle Aged; Paroxetine; Personality Inventory; Psychometrics; Stress Disorders, Post-Traumatic; Substance P; Treatment Outcome | 2011 |
Gender differences in reduced substance P (SP) in children with slow-transit constipation.
Topics: Active Transport, Cell Nucleus; Adolescent; Biopsy; Child; Child, Preschool; Chronic Disease; Colon, Transverse; Constipation; Female; Follow-Up Studies; Gastrointestinal Transit; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Prevalence; Radionuclide Imaging; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sex Factors; Substance P; Victoria | 2011 |
Cough reflex sensitivity and airway inflammation in patients with chronic cough due to non-acid gastro-oesophageal reflux.
Topics: Adult; Aged; Asthma; Capsaicin; Chronic Disease; Cough; Cross-Sectional Studies; Female; Gastroesophageal Reflux; Histamine; Humans; Male; Middle Aged; Prospective Studies; Prostaglandin D2; Reflex; Respiratory Function Tests; Sputum; Substance P; Tryptases | 2011 |
Substance P alterations in skin and brain of chronically stressed atopic-like mice.
Topics: Animals; Base Sequence; Brain; Chronic Disease; Dermatitis, Atopic; DNA Primers; Female; Immunohistochemistry; Mice; Polymerase Chain Reaction; Skin; Stress, Physiological; Substance P | 2013 |
Substance P and vasoactive intestinal peptide levels in middle ear effusions of children.
Topics: Age Factors; Biomarkers; Child; Child, Preschool; Chronic Disease; Cohort Studies; Disease Progression; Female; Humans; Male; Otitis Media with Effusion; Prognosis; Prospective Studies; Recurrence; Sensitivity and Specificity; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Substance P; Vasoactive Intestinal Peptide | 2012 |
Management of chronic pain in whiplash injury.
Topics: Adult; Calcitonin Gene-Related Peptide; Chronic Disease; Decompression, Surgical; Diagnostic Techniques, Neurological; Female; Humans; Male; Median Nerve; Neck Pain; Prospective Studies; Shoulder Pain; Substance P; Trauma, Nervous System; Treatment Outcome; Whiplash Injuries | 2002 |
[Chronic rhinosinusitis in hypogammaglobulinemia. A morphological study].
Topics: Adult; Agammaglobulinemia; Calcitonin Gene-Related Peptide; Chronic Disease; Gene Expression; Genes, Recessive; Humans; Male; Microscopy, Immunoelectron; Nasal Mucosa; Rhinitis; Sex Chromosome Aberrations; Sinusitis; Substance P; Turbinates; X Chromosome | 2002 |
Altered diurnal pattern of salivary substance P in adults with developmental disabilities and chronic self-injury.
Topics: Adult; Chronic Disease; Circadian Rhythm; Female; Humans; Hydrocortisone; Intellectual Disability; Male; Nociceptors; Saliva; Self-Injurious Behavior; Substance P | 2003 |
[Repeated 100 Hz TENS for the treatment of chronic inflammatory pain in rats: optimal parameters and possible neuro-chemical mechanisms].
Topics: Animals; Arthralgia; Arthritis, Experimental; Chronic Disease; Dynorphins; Naltrexone; Pain Threshold; Rats; Substance P; Transcutaneous Electric Nerve Stimulation | 1999 |
Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations.
Topics: Amylases; Analgesics, Opioid; Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Immunohistochemistry; Lipase; Male; Morphine; Neuropeptides; Organotin Compounds; Pain; Pain Measurement; Pancreas; Pancreatitis; Physical Stimulation; Rats; Rats, Inbred Lew; Substance P | 2003 |
Changes in nasal mucosal innervation in horses with grass sickness.
Topics: Acute Disease; Animals; Autonomic Nervous System Diseases; Biomarkers; Calcitonin Gene-Related Peptide; Chronic Disease; Horse Diseases; Horses; Immunohistochemistry; Intermediate Filament Proteins; Intermediate Filaments; Nasal Mucosa; Nerve Fibers; Rhinitis; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase | 2003 |
Direct interstitial infusion of NK1-targeted neurotoxin into the spinal cord: a computational model.
Topics: Chronic Disease; Extracellular Space; Humans; Models, Biological; Neurotoxins; Pain; Receptors, Neurokinin-1; Spinal Cord; Substance P | 2003 |
Chronic idiopathic slow transit constipation: pathophysiology and management.
Topics: Autonomic Nervous System; Chronic Disease; Constipation; Gastrointestinal Transit; Humans; Neurosecretory Systems; Peptide YY; Substance P | 2003 |
Substance P expression correlates with severity of diarrhea in cryptosporidiosis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Animals; Chronic Disease; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Jejunum; Male; Middle Aged; RNA, Messenger; Substance P | 2003 |
Molecular plasticity of primary nociceptive neurons: relations of the NGF-c-jun system to neurotomy and chronic pain.
Topics: Animals; Atrophy; Calcitonin Gene-Related Peptide; Chronic Disease; Female; Functional Laterality; Ganglia, Spinal; Male; Models, Neurological; Nerve Growth Factor; Neuronal Plasticity; Neurons; Nociceptors; Pain; Proto-Oncogene Proteins c-jun; Rats; Substance P; Vincristine | 2003 |
Substance P regulates Th1-type colitis in IL-10 knockout mice.
Topics: Animals; Cells, Cultured; Chronic Disease; Colitis; Disease Models, Animal; Interleukin-10; Interleukin-12; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Piroxicam; Receptors, Neurokinin-1; RNA, Messenger; Substance P; Th1 Cells | 2003 |
Hypothalamic response to experimental allergic encephalomyelitis: role of substance P.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Body Weight; Chronic Disease; Corticosterone; Encephalomyelitis, Autoimmune, Experimental; Hypothalamus; Indoles; Isoindoles; Male; Mesencephalon; Neuroimmunomodulation; Neurokinin-1 Receptor Antagonists; Rats; Rats, Inbred Lew; Stress, Physiological; Substance P | 2004 |
Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin.
Topics: Administration, Inhalation; Adult; Capsaicin; Case-Control Studies; Cetirizine; Chronic Disease; Cough; Disease Susceptibility; Ephedrine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Nasal Decongestants; Nasal Lavage Fluid; Nasal Provocation Tests; Osmolar Concentration; Substance P | 2003 |
[Expression and significance of substance P, neurofilament-H in glomus tumors with chronic pain].
Topics: Adult; Aged; Chronic Disease; Female; Glomus Tumor; Humans; Immunohistochemistry; Male; Middle Aged; Neurofilament Proteins; Pain, Intractable; Substance P | 2003 |
Substance P expression is elevated in inflamed human periradicular tissue.
Topics: Acute Disease; Chronic Disease; Humans; Neurogenic Inflammation; Neutrophils; Periapical Granuloma; Substance P | 2004 |
Sustained potentiation by substance P of NMDA-activated current in rat primary sensory neurons.
Topics: Animals; Benzylamines; Calcium Signaling; Cell Membrane; Cells, Cultured; Chelating Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Synergism; Egtazic Acid; Enzyme Inhibitors; Ganglia, Spinal; Membrane Potentials; Models, Biological; N-Methylaspartate; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Pain; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, N-Methyl-D-Aspartate; Receptors, Neurokinin-1; Substance P; Sulfonamides | 2004 |
Motor responses of rat hypertrophic intestine following chronic obstruction.
Topics: Acetylcholine; Animals; Chronic Disease; Electric Stimulation; Female; Gastrointestinal Motility; Hypertrophy; Intestinal Obstruction; Intestines; Muscle Contraction; Muscle, Smooth; Organ Culture Techniques; Rats; Rats, Wistar; Substance P | 2004 |
Stress-induced modulation of skin immune function: two types of antigen-presenting cells in the epidermis are differentially regulated by chronic stress.
Topics: Animals; Antigen-Presenting Cells; Cadherins; Cell Differentiation; Cell Division; Chronic Disease; Corticosterone; Dermatitis, Contact; Immunization; Interleukin-1; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Models, Animal; Picryl Chloride; Skin; Social Isolation; Stress, Psychological; Substance P; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
[Research of the P substance on the olfactory mucous in sinusitis].
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Humans; Male; Middle Aged; Olfactory Mucosa; Sinusitis; Substance P | 2004 |
Morphological changes in the rat carotid body 1, 2, 4, and 8 weeks after the termination of chronically hypocapnic hypoxia.
Topics: Animals; Calcitonin Gene-Related Peptide; Carotid Body; Chronic Disease; Hypocapnia; Hypoxia; Immunohistochemistry; Nerve Fibers; Neuropeptide Y; Peptide Fragments; Rats; Rats, Wistar; Substance P; Time Factors; Vasoactive Intestinal Peptide | 2004 |
Neuropeptide expression in rats exposed to chronic mild stresses.
Topics: Amygdala; Animals; Arcuate Nucleus of Hypothalamus; Brain; Brain Mapping; Chronic Disease; Dentate Gyrus; Depressive Disorder, Major; Disease Models, Animal; Galanin; Gene Expression Regulation; Hypothalamus; Male; Neuropeptide Y; Neuropeptides; Rats; Rats, Wistar; RNA, Messenger; Self Stimulation; Stress, Psychological; Substance P | 2005 |
No evidence of increased serum substance P levels in chronic urticaria patients with and without demonstrable circulating vasoactive factors.
Topics: Adult; Basophil Degranulation Test; Biomarkers, Tumor; Chronic Disease; Humans; Hypersensitivity, Immediate; Skin Tests; Substance P; Tumor Protein, Translationally-Controlled 1; Urticaria | 2005 |
Study of substance P, renin and aldosterone in chronic liver disease in Egyptian children.
Topics: Aldosterone; Case-Control Studies; Child; Chronic Disease; Egypt; Female; Humans; Liver Diseases; Male; Renin; Substance P | 2005 |
Molecular and behavioral changes in nociception in a novel rat model of chronic pancreatitis for the study of pain.
Topics: Amylases; Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Radiation; Electric Stimulation; Enzyme-Linked Immunosorbent Assay; Ganglia, Spinal; Gene Expression Regulation; Immunohistochemistry; Male; Nerve Growth Factor; Nociceptors; Pain; Pain Measurement; Pancreatitis; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance P; Time Factors; Trinitrobenzenesulfonic Acid | 2005 |
Spinal neuropeptide responses in persistent and transient pain following cervical nerve root injury.
Topics: Acute Disease; Animals; Calcitonin Gene-Related Peptide; Cervical Vertebrae; Chronic Disease; Hyperalgesia; Immunohistochemistry; Male; Neck Pain; Neuralgia; Radiculopathy; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerve Roots; Substance P | 2005 |
Morphological changes in the rat carotid body in acclimatization and deacclimatization to hypoxia.
Topics: Acclimatization; Animals; Calcitonin Gene-Related Peptide; Carotid Body; Chronic Disease; Hypoxia; Neuropeptide Y; Rats; Substance P; Time Factors; Vasoactive Intestinal Peptide | 2006 |
Effect of carbon dioxide on the structure of the carotid body: a comparison between normoxic and hypoxic conditions.
Topics: Animals; Calcitonin Gene-Related Peptide; Carbon Dioxide; Carotid Body; Chronic Disease; Hypercapnia; Hypocapnia; Hypoxia; Neuropeptide Y; Rats; Substance P; Time Factors; Vasoactive Intestinal Peptide; Vasodilation | 2006 |
Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides.
Topics: Anesthesia; Anesthetics, Intravenous; Animals; Bradykinin; Capsaicin; Chronic Disease; Colitis; Cystitis, Interstitial; Female; Mast Cells; Nerve Endings; Nerve Fibers, Unmyelinated; Neurons, Afferent; Neuropeptides; Pelvis; Physical Stimulation; Rats; Rats, Sprague-Dawley; Substance P; Trinitrobenzenesulfonic Acid; Urethane; Urinary Bladder | 2007 |
Local and descending circuits regulate long-term potentiation and zif268 expression in spinal neurons.
Topics: Animals; Chronic Disease; Early Growth Response Protein 1; Efferent Pathways; Hot Temperature; Hyperalgesia; Long-Term Potentiation; Male; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Nociceptors; Oligonucleotides, Antisense; Pain; Physical Stimulation; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Substance P; Synaptic Transmission | 2006 |
Substance P receptor mediated maintenance of chronic inflammation in EAE.
Topics: Animals; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; Chronic Disease; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Immunity, Cellular; Immunosuppression Therapy; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neuroimmunomodulation; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Receptors, Neurokinin-1; Substance P | 2006 |
Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse.
Topics: Acute Disease; Animals; beta-Endorphin; CD4-Positive T-Lymphocytes; Chronic Disease; Colitis; Colon; Compliance; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Neuropeptides; Pain; Pain Threshold; Physical Stimulation; Receptors, Opioid, mu; Substance P | 2007 |
Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.
Topics: Animals; Brain; CD4-Positive T-Lymphocytes; Chronic Disease; Dermatitis; Dermis; Epidermis; Female; Gene Expression; Homeostasis; Hypertrophy; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Endings; Pruritus; Receptors, Opioid, kappa; Receptors, Opioid, mu; RNA, Messenger; Substance P; Ubiquitin Thiolesterase | 2007 |
Participation of capsaicin-sensitive afferent nerves in the gastric mucosa of patients with Helicobacter pylori-positive or-negative chronic gastritis.
Topics: Adult; Afferent Pathways; Aged; Breath Tests; Calcitonin Gene-Related Peptide; Capsaicin; Chronic Disease; Dyspepsia; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Male; Middle Aged; Substance P; TRPV Cation Channels; Urea; Urease | 2007 |
Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Topics: Adult; Aged; Chronic Disease; Female; Gene Expression Regulation; Humans; Hydrocortisone; Male; Middle Aged; Pain Measurement; Pruritus; Psoriasis; Receptors, Neurokinin-1; Saliva; Skin; Stress, Psychological; Substance P | 2007 |
[Activation of astrocytes effects changes of substance P in cornu dorsal medullae spinalis in chronic prostatitis rats].
Topics: Animals; Astrocytes; Chronic Disease; Male; Prostatitis; Random Allocation; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 2007 |
Nerve-related characteristics of ventral paratendinous tissue in chronic Achilles tendinosis.
Topics: Achilles Tendon; Adult; Aged; Antibodies; Biopsy; Calcitonin Gene-Related Peptide; Chronic Disease; Female; Humans; Male; Middle Aged; Nerve Fibers; Receptors, Adrenergic, alpha-1; Receptors, Neurokinin-1; Substance P; Tendinopathy; Tyrosine 3-Monooxygenase; Ubiquitin Thiolesterase | 2007 |
Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cytokines; Dinoprostone; Diphosphonates; Drug Evaluation, Preclinical; Edema; Foot; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Ibandronic Acid; Inflammation; Interleukin-1beta; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Tumor Necrosis Factor-alpha | 2008 |
The differential effects of emotional or physical stress on pain behaviors or on c-Fos immunoreactivity in paraventricular nucleus or arcuate nucleus.
Topics: Analysis of Variance; Animals; Arcuate Nucleus of Hypothalamus; Chronic Disease; Disease Models, Animal; Glutamic Acid; Immunohistochemistry; Injections, Spinal; Interferon-gamma; Interleukin-1beta; Male; Mice; Mice, Inbred ICR; Pain; Pain Threshold; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Statistics, Nonparametric; Stress, Psychological; Substance P; Tumor Necrosis Factor-alpha | 2008 |
[Clinical significance of the functional and structural changes in the intestines in chronic cholecystitis].
Topics: Adult; Aged; Atrophy; Cholecystitis; Cholelithiasis; Chronic Disease; Colonic Polyps; Diagnosis, Differential; Erythrocyte Count; Erythrocytes; Female; Humans; Inflammation; Intestinal Mucosa; Male; Middle Aged; Motilin; Predictive Value of Tests; Prognosis; Substance P | 2007 |
Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response.
Topics: Adult; Alleles; Angioedema; Case-Control Studies; Chronic Disease; Disease Susceptibility; Female; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Substance P; Urticaria | 2008 |
[Effect of electroacupuncture of local plus distal acupoints in the same segments of spinal cord on spinal substance P expression in rats with chronic radicular pain].
Topics: Acupuncture Points; Animals; Chronic Disease; Electroacupuncture; Motor Activity; Pain Management; Pain Threshold; Random Allocation; Rats; Rats, Wistar; Spinal Cord; Substance P | 2008 |
Neural and hormonal peptides in rectal biopsy specimens from patients with Chagas' disease and chronic autonomic failure.
Topics: Autonomic Nervous System; Biopsy; Chagas Disease; Chronic Disease; Gastrointestinal Hormones; Humans; Intestinal Diseases, Parasitic; Nervous System Diseases; Rectum; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1980 |
[Substance P and pain: possible pathogenic role in chronic primary headache].
Topics: Chronic Disease; Headache; Humans; Pain; Substance P | 1980 |
Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress.
Topics: Adrenocorticotropic Hormone; Animals; Arthritis, Experimental; Chronic Disease; Corticotropin-Releasing Hormone; Hypothalamus; Inflammation; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Physiological; Substance P | 1995 |
Innervation of recurrent aphthous ulcers.
Topics: Adult; Calcitonin Gene-Related Peptide; Chronic Disease; Female; Humans; Male; Middle Aged; Mouth Mucosa; Pain; Recurrence; Stomatitis, Aphthous; Substance P | 1994 |
Differential effects of experimentally induced chronic pancreatitis on neuropeptide immunoreactivities in the feline pancreas.
Topics: Animals; Calcitonin Gene-Related Peptide; Cats; Chronic Disease; Constriction; Female; Gastrin-Releasing Peptide; Immunohistochemistry; Male; Neuropeptide Y; Neuropeptides; Pancreas; Pancreatic Ducts; Pancreatitis; Peptides; Substance P; Tachykinins; Vasoactive Intestinal Peptide | 1993 |
[Met-enkephalin and substance P. Comparison of CSF levels in patients with chronic pain based on a sampling procedure].
Topics: Adult; Aged; Chronic Disease; Enkephalin, Methionine; Female; Humans; Male; Middle Aged; Pain; Sampling Studies; Spinal Puncture; Substance P; Ventriculoperitoneal Shunt | 1993 |
Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats.
Topics: Animals; Arginine; Chronic Disease; Hypertension; Hypoxia; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Substance P; Vasoconstriction | 1994 |
Prevaccination with diluted Freund adjuvant prevents the development of chronic pain and transient release of cerebrospinal fluid substance P in adjuvant-induced arthritis in rats.
Topics: Animals; Arthritis, Experimental; Behavior, Animal; Body Weight; Chronic Disease; Freund's Adjuvant; Hindlimb; Motor Activity; Pain; Pain Measurement; Rats; Substance P; Vaccination; Vocalization, Animal | 1994 |
Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis.
Topics: Adult; Aged; Asthma; Bronchial Provocation Tests; Bronchitis; Chronic Disease; Eosinophils; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Radioimmunoassay; Saline Solution, Hypertonic; Sputum; Substance P; Vital Capacity | 1995 |
Capsaicin pretreatment attenuates chronic hypoxic pulmonary hypertension.
Topics: Animals; Blood Pressure; Capsaicin; Chronic Disease; Female; Hypertension, Pulmonary; Hypoxia; Neprilysin; Pulmonary Circulation; Random Allocation; Rats; Rats, Wistar; Substance P; Tachykinins | 1995 |
Changes in neuroendocrine elements in bronchial mucosa in chronic lung disease in adults.
Topics: Adult; Aged; Bronchi; Calcitonin; Calcitonin Gene-Related Peptide; Chromogranin A; Chromogranins; Chronic Disease; Gastrin-Releasing Peptide; Gastrins; Humans; Immunohistochemistry; Lung Diseases; Middle Aged; Mucous Membrane; Neurosecretory Systems; Peptides; Serotonin; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase | 1995 |
Neuropeptide changes in compressed spinal nerve roots.
Topics: Animals; Chronic Disease; Disease Models, Animal; Female; Ganglia, Spinal; Male; Nerve Compression Syndromes; Spinal Nerve Roots; Substance P; Swine; Vasoactive Intestinal Peptide | 1995 |
Effects of chronic hypoxia on the secretory responses of rat salivary glands.
Topics: Animals; Barotrauma; Chronic Disease; Female; Hypoxia; Isoproterenol; Methacholine Chloride; Methoxamine; Parotid Gland; Rats; Rats, Wistar; Saliva; Salivary Glands; Secretory Rate; Stimulation, Chemical; Submandibular Gland; Substance P; Xerostomia | 1995 |
An immunocytochemical study on relations between mast cell and peptidergic terminals in nasal mucosa of chronic rhinitis patients.
Topics: Adult; Chronic Disease; Female; Humans; Immunohistochemistry; Male; Mast Cells; Nasal Mucosa; Nerve Endings; Rhinitis; Substance P | 1995 |
Substance P levels in the rectal mucosa of diabetic patients with normal bowel function and constipation.
Topics: Adult; Chronic Disease; Constipation; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Radioimmunoassay; Rectum; Substance P | 1993 |
Substance P-like immunoreactivity and analgesic effects of vibratory stimulation on patients suffering from chronic pain.
Topics: Adult; Aged; Analgesia; Chronic Disease; Female; Humans; Male; Middle Aged; Pain; Pain Management; Pain Measurement; Physical Stimulation; Radioimmunoassay; Substance P; Vibration | 1993 |
Immunoreactive substance P in human saliva. A possible marker of chronic pain.
Topics: Adult; Biomarkers; Blood Proteins; Chronic Disease; Humans; Low Back Pain; Middle Aged; Saliva; Salivary Proteins and Peptides; Substance P | 1993 |
Evidence for altered control of hypothalamic CRF in immune-mediated diseases.
Topics: Acute Disease; Animals; Arginine Vasopressin; Arthritis, Experimental; Chronic Disease; Corticotropin-Releasing Hormone; Hypothalamo-Hypophyseal System; Hypothalamus; Inflammation; Mice; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Stress, Physiological; Substance P | 1995 |
Substance P content and preprotachykinin gene-I mRNA expression in a rat model of chronic bronchitis.
Topics: Animals; Base Sequence; Bronchitis; Chronic Disease; Disease Models, Animal; Ganglia, Spinal; Gene Expression; Lung; Molecular Sequence Data; Nodose Ganglion; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Sulfur Dioxide; Tachykinins; Trachea | 1996 |
Chromic gut suture reduces calcitonin-gene-related peptide and substance P levels in the spinal cord following chronic constriction injury in the rat.
Topics: Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Chromium Compounds; Chronic Disease; Constriction, Pathologic; Male; Nerve Tissue Proteins; Pain; Peripheral Nerve Injuries; Peripheral Nerves; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Substance P; Sutures | 1996 |
Pre- and postnatal effects of chronic maternal hypoxia on substance-P immunoreactivity in rabbit brainstem regions.
Topics: Animals; Brain Stem; Chronic Disease; Female; Hypoxia; Immunohistochemistry; Pregnancy; Prenatal Exposure Delayed Effects; Rabbits; Substance P | 1995 |
Intestinal neuronal dysplasia. Defining a new cause for chronic constipation.
Topics: Chronic Disease; Constipation; Gastrointestinal Motility; Humans; Self-Help Groups; Substance P | 1996 |
Chronic parasite infection in mice induces brain granulomas and differentially alters brain nerve growth factor levels and thermal responses in paws.
Topics: Animals; Brain; Burns; Chronic Disease; Extremities; Female; Granuloma; Mice; Mice, Inbred Strains; Nerve Growth Factors; Physical Stimulation; Schistosoma mansoni; Schistosomiasis mansoni; Substance P | 1996 |
Alteration in central and peripheral substance P- and neuropeptide Y-like immunoreactivity after chronic hypoxia in the rat.
Topics: Adrenal Glands; Animals; Antibodies; Brain Chemistry; Carotid Body; Chronic Disease; Ganglia, Sympathetic; Hypoxia; Male; Neuropeptide Y; Pituitary Gland, Anterior; Proteins; Radioimmunoassay; Rats; Rats, Inbred Strains; Substance P | 1996 |
Chronic placental insufficiency in the fetal guinea pig affects neurochemical and neuroglial development but not neuronal numbers in the brainstem: a new method for combined stereology and immunohistochemistry.
Topics: Animals; Brain Chemistry; Brain Stem; Cell Count; Chronic Disease; Enkephalin, Methionine; Female; Fetal Growth Retardation; Glial Fibrillary Acidic Protein; Guinea Pigs; Hypoglossal Nerve; Immunohistochemistry; Neuroglia; Placental Insufficiency; Pregnancy; Substance P | 1997 |
Distribution of substance P and calcitonin gene-related peptide immunoreactive nerve fibers in the trachea of chronically hypoxic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Chronic Disease; Hypoxia; Immunohistochemistry; Male; Nerve Fibers; Rats; Rats, Sprague-Dawley; Reference Values; Substance P; Trachea | 1996 |
Effect of chronic myocardial infarction on in vivo reactivity of skeletal muscle arterioles.
Topics: Acetylcholine; Animals; Arginine; Arterioles; Calcitonin Gene-Related Peptide; Chronic Disease; Hemodynamics; Male; Muscle, Skeletal; Myocardial Infarction; Nitroprusside; Rats; Rats, Sprague-Dawley; Substance P; Vasomotor System | 1997 |
Deficiency of substance P-immunoreactive nerve fibres in children with intractable constipation: a form of intestinal neuronal dysplasia.
Topics: Biopsy; Child; Chronic Disease; Colon; Constipation; Gastrointestinal Motility; Humans; Nerve Fibers; Substance P | 1997 |
Renal function of substance P in rats chronically exposed to hypoxia.
Topics: Altitude Sickness; Animals; Chronic Disease; Disease Models, Animal; Female; Glomerular Filtration Rate; Hypoxia; Infusions, Intravenous; Kallikreins; Kidney; Rats; Rats, Wistar; Sodium; Substance P | 1997 |
Effects of experimental Mycoplasma pulmonis infection on sensory neuropeptides and airway mucosa in the rat.
Topics: Animals; Blotting, Northern; Calcitonin Gene-Related Peptide; Chronic Disease; Culture Techniques; Disease Models, Animal; Immunohistochemistry; Male; Mucous Membrane; Mycoplasma Infections; Nasal Mucosa; Neuropeptides; Rats; Rats, Inbred Strains; Respiratory Tract Infections; Substance P; Trachea; Trigeminal Ganglion | 1997 |
Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Bronchi; Bronchitis; Calcitonin Gene-Related Peptide; Chronic Disease; Exocrine Glands; Humans; Immunohistochemistry; Male; Middle Aged; Mucus; Nerve Tissue Proteins; Neurons; Smoking; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 1997 |
Temporal changes in spinal cord expression of mRNA for substance P, dynorphin and enkephalin in a model of chronic pain.
Topics: Animals; Behavior, Animal; Chronic Disease; Disease Models, Animal; Dynorphins; Enkephalins; Gene Expression; Male; Neuropeptides; Pain; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spinal Cord; Substance P; Time Factors | 1997 |
Innervation of nasal turbinate blood vessels in rhinitic and nonrhinitic children.
Topics: Arteries; Arteriovenous Anastomosis; Blood Vessels; Calcitonin Gene-Related Peptide; Child; Child, Preschool; Chronic Disease; Humans; Immunohistochemistry; Nasal Mucosa; Nerve Fibers; Nerve Tissue Proteins; Neuropeptide Y; Peptide Fragments; Rhinitis; Substance P; Thiolester Hydrolases; Turbinates; Ubiquitin Thiolesterase | 1998 |
Attenuation of isocapnic hyperpnoea-induced guinea-pig bronchoconstriction by chronic hypoxia.
Topics: Animals; Bronchial Spasm; Capsaicin; Carbon Dioxide; Chronic Disease; Forced Expiratory Volume; Guinea Pigs; Hypoxia; Lung; Male; Neprilysin; Pulmonary Ventilation; Respiration; Substance P; Trachea | 1998 |
Pain treatment of fibromyalgia by acupuncture.
Topics: Acupuncture Therapy; Biomarkers; Blood Platelets; Chronic Disease; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Pain Management; Pain Measurement; Platelet Count; Serotonin; Substance P; Treatment Outcome | 1998 |
Calcitonin gene-related peptide mediates the protective effect of sensory nerves in a model of colonic injury.
Topics: Animals; Antibodies, Monoclonal; Calcitonin Gene-Related Peptide; Chronic Disease; Colitis, Ulcerative; Indoles; Isoindoles; Male; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Protein Biosynthesis; Rats; Rats, Wistar; Substance P | 1998 |
Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases.
Topics: Administration, Oral; Adolescent; Adult; Aged; Asthma; Beclomethasone; Biomarkers; Biopsy; Bronchi; Bronchitis; Bronchoconstriction; Calcitonin Gene-Related Peptide; Capillary Permeability; Chronic Disease; Epithelium; Female; Fluorescent Antibody Technique, Direct; Glucocorticoids; Humans; Male; Middle Aged; Mucous Membrane; Muscle, Smooth; Nerve Tissue Proteins; Neuropeptide Y; Neuropeptides; Prednisone; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide; Vasomotor System | 1998 |
[A study on the cumulative effect of repeated electroacupuncture on chronic pain].
Topics: Acupuncture Analgesia; Animals; Arthritis, Experimental; Chronic Disease; Electroacupuncture; Humans; Pain Management; Rats; Sincalide; Substance P | 1996 |
Angiogenesis in mice with chronic airway inflammation: strain-dependent differences.
Topics: Animals; Capillary Permeability; Cell Count; Chronic Disease; Endothelium, Vascular; Evans Blue; Female; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neovascularization, Pathologic; Pneumonia, Mycoplasma; Silver Staining; Species Specificity; Specific Pathogen-Free Organisms; Substance P; Trachea; Tracheitis; Wheat Germ Agglutinins | 1998 |
Antioxidants attenuate chronic hypoxic pulmonary hypertension.
Topics: Animals; Antioxidants; Body Weight; Chronic Disease; Free Radicals; Hypertension, Pulmonary; Hypoxia; Male; Rats; Rats, Wistar; Substance P; Thiourea | 1998 |
Relationship between neuronal activity and substance P-immunoreactivity in the rat spinal cord during acute and persistent myositis.
Topics: Acute Disease; Animals; Carrageenan; Chronic Disease; Electric Stimulation; Freund's Adjuvant; Male; Myositis; Neurons; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P; Time Factors | 1998 |
Cholinergic stimulation and nonadrenergic, noncholinergic relaxation of human colonic circular muscle in idiopathic chronic constipation.
Topics: Acetylcholine; Adenosine Triphosphate; Adult; Atropine; Cholinergic Fibers; Chronic Disease; Colon; Constipation; Electric Stimulation; Gastrointestinal Motility; Guanethidine; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Substance P; Vasoactive Intestinal Peptide | 1998 |
Free radicals contribute to the reduction in peripheral vascular responses and the maintenance of thermal hyperalgesia in rats with chronic constriction injury.
Topics: Animals; Antioxidants; Behavior, Animal; Chronic Disease; Constriction, Pathologic; Free Radicals; Hyperalgesia; Male; Peripheral Nerve Injuries; Pregnatrienes; Rats; Rats, Sprague-Dawley; Skin; Substance P; Superoxide Dismutase; Temperature; Vasodilation | 1999 |
Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain.
Topics: Acute Disease; Animals; Carrageenan; Chronic Disease; Constriction, Pathologic; Diphtheria Toxin; Hyperalgesia; Immunohistochemistry; Inflammation; Injections, Spinal; Male; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Sciatic Nerve; Substance P | 1999 |
Chronic pain is associated with increased TrkA immunoreactivity in spinoreticular neurons.
Topics: Afferent Pathways; Animals; Arthritis, Experimental; Calcitonin Gene-Related Peptide; Cell Count; Cell Size; Chronic Disease; Immunohistochemistry; Lumbosacral Region; Male; Nerve Growth Factors; Neuronal Plasticity; Neurons; Pain; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, trkA; Receptors, Nerve Growth Factor; Spinal Cord; Substance P | 1999 |
Rat model of Achilles tendon disorder. A pilot study.
Topics: Achilles Tendon; Animals; Biomechanical Phenomena; Calcitonin Gene-Related Peptide; Chronic Disease; Collagen; Cumulative Trauma Disorders; Disease Models, Animal; Gait; Hindlimb; Hip Joint; Male; Peripheral Nerves; Physical Conditioning, Animal; Pilot Projects; Rats; Rats, Sprague-Dawley; Substance P; Torque | 1999 |
Vasoactive-intestinal-peptide- and substance-P-immunoreactive nerve fibres in the myenteric plexus of mouse colon during the chronic phase of Trypanosoma cruzi infection.
Topics: Animals; Chagas Disease; Chronic Disease; Colon; Immunohistochemistry; Male; Mice; Microscopy, Electron; Myenteric Plexus; Neurons; Substance P; Vacuoles; Vasoactive Intestinal Peptide | 1999 |
Loss of nerve: a molecular approach to better treatment of chronic pain.
Topics: Animals; Chronic Disease; Humans; Immunotoxins; N-Glycosyl Hydrolases; Neurosurgical Procedures; Pain, Intractable; Plant Proteins; Ribosome Inactivating Proteins, Type 1; Ricin; Saporins; Sensory Receptor Cells; Substance P | 2000 |
Changes in the peptidergic innervation of the rat carotid body a month after the termination of chronic hypoxia.
Topics: Animals; Calcitonin Gene-Related Peptide; Carotid Body; Chronic Disease; Hypoxia; Immunohistochemistry; Neuropeptide Y; Neuropeptides; Rats; Substance P; Time Factors; Vasoactive Intestinal Peptide | 2000 |
Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis.
Topics: Adult; Blotting, Northern; Case-Control Studies; Chronic Disease; Female; Gene Expression; Humans; Interleukin-8; Male; Middle Aged; Pancreas; Pancreatic Ducts; Pancreatitis; Protein Precursors; RNA, Messenger; Substance P; Tachykinins | 2000 |
Disorder-specific changes in innervation in oral lichen planus and lichenoid reactions.
Topics: Adult; Aged; Analysis of Variance; Basement Membrane; Calcitonin Gene-Related Peptide; Chronic Disease; Humans; Lichen Planus, Oral; Lichenoid Eruptions; Middle Aged; Mouth Diseases; Mouth Mucosa; Nerve Fibers; Nerve Tissue Proteins; Neuropeptide Y; Statistics, Nonparametric; Stomatitis; Substance P; Sympathetic Nervous System; Thiolester Hydrolases; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 2000 |
The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Chronic Disease; Cytokines; Electric Stimulation; Humans; Knee Joint; Macrophages; Middle Aged; Nerve Fibers; Norepinephrine; Osteoarthritis; Sensory Receptor Cells; Substance P; Sympathetic Nervous System; Synovial Membrane | 2000 |
Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis.
Topics: Animals; Attention; Chronic Disease; Dermatitis; Female; Histamine; Immunoglobulin E; Mice; Mice, Inbred Strains; Mites; Naltrexone; Narcotic Antagonists; Pruritus; Serotonin; Substance P | 2001 |
Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P.
Topics: Albuterol; Animals; Bronchodilator Agents; Capillary Permeability; Chronic Disease; Dose-Response Relationship, Drug; Drug Hypersensitivity; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Indoles; Male; Mycoplasma Infections; Organ Size; Organometallic Compounds; Platelet Activating Factor; Rats; Rats, Inbred F344; Rats, Wistar; Salmeterol Xinafoate; Serotonin; Species Specificity; Specific Pathogen-Free Organisms; Substance P; Trachea | 2001 |
[No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Chronic Disease; Cough; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Nephritis; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Substance P | 2001 |
Influence of painful chronic neuropathy on neurogenic inflammation.
Topics: Administration, Topical; Analgesics; Animals; Capsaicin; Chronic Disease; Coloring Agents; Electric Stimulation; Evans Blue; Hot Temperature; Indoles; Isoindoles; Ligation; Male; Nerve Fibers; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Sciatic Nerve; Sciatica; Substance P | 2001 |
Substance P in rectal mucosa of children with chronic constipation.
Topics: Case-Control Studies; Child; Child, Preschool; Chronic Disease; Constipation; Female; Follow-Up Studies; Humans; Infant; Intestinal Mucosa; Male; Radioimmunoassay; Substance P | 2001 |
Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation.
Topics: Adult; Aged; Aged, 80 and over; Carbachol; Cholinergic Agonists; Chronic Disease; Colon; Constipation; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Receptors, Neurokinin-2; Receptors, Tachykinin; Substance P | 2001 |
Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients.
Topics: Adult; Calcitonin Gene-Related Peptide; Chronic Disease; Circadian Rhythm; Female; Headache; Humans; Male; Middle Aged; Nerve Growth Factor; Reference Values; Substance P | 2001 |
Presence and distribution of sensory nerve fibers in human peritoneal adhesions.
Topics: Calcitonin Gene-Related Peptide; Chronic Disease; Humans; Laparoscopy; Microscopy, Electron; Nerve Fibers; Nociceptors; Pelvic Pain; Peritoneum; Substance P; Tissue Adhesions | 2001 |
Decreases in endomorphin-2-like immunoreactivity concomitant with chronic pain after nerve injury.
Topics: Animals; Calcitonin Gene-Related Peptide; Chronic Disease; Down-Regulation; Functional Laterality; Hyperalgesia; Immunohistochemistry; Ligation; Male; Mice; Mice, Inbred ICR; Nerve Crush; Neuralgia; Oligopeptides; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Posterior Horn Cells; Reaction Time; Sciatic Nerve; Substance P | 2001 |
Spontaneous chronic corneal epithelial defects (SCCED) in dogs: clinical features, innervation, and effect of topical SP, with or without IGF-1.
Topics: Administration, Topical; Animals; Calcitonin Gene-Related Peptide; Chronic Disease; Corneal Diseases; Dog Diseases; Dogs; Drug Therapy, Combination; Epithelium, Corneal; Female; Fluorophotometry; Immunoenzyme Techniques; Insulin-Like Growth Factor I; Male; Substance P; Thiolester Hydrolases; Trigeminal Nerve; Tyrosine 3-Monooxygenase; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 2001 |
An investigation of immunocompetence substances in normal gingival and periodontitis tissue.
Topics: Adult; Calcitonin Gene-Related Peptide; Chronic Disease; Endothelins; Female; Gingiva; Humans; Immunohistochemistry; Male; Nitric Oxide; Periodontitis; Protein Biosynthesis; Substance P | 2000 |
Temporal increase in the reactivity of pulmonary vasculature to substance P in chronically hypoxic rats.
Topics: Altitude; Animals; Blood Pressure; Blood Vessels; Capillaries; Chronic Disease; Female; Hypoxia; In Vitro Techniques; Piperidines; Pulmonary Circulation; Quinuclidines; Rats; Rats, Wistar; Receptors, Neurokinin-1; Receptors, Neurokinin-2; RNA, Messenger; Substance P; Time Factors | 2002 |
Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa.
Topics: Animals; Chronic Disease; Dipeptidyl Peptidase 4; Humans; Models, Biological; Nasal Mucosa; Rhinitis; Substance P; Swine; Vascular Resistance; Vasodilator Agents | 2002 |
Temporal decrease in renal sensory responses in rats after chronic ligation of the bile duct.
Topics: Animals; Cholestasis; Chronic Disease; Disease Models, Animal; Gene Expression; Kidney; Ligation; Liver Cirrhosis, Biliary; Male; Neurons, Afferent; Physical Stimulation; Rats; Rats, Wistar; Receptors, Neurokinin-1; Reflex; RNA, Messenger; Sodium Chloride; Substance P; Urinary Catheterization; Urine | 2002 |
Autoradiographic analysis of 125I-substance P binding in rat spinal cord following chronic constriction injury of the sciatic nerve.
Topics: Animals; Autoradiography; Chronic Disease; Constriction, Pathologic; Defense Mechanisms; Indicators and Reagents; Iodine Radioisotopes; Male; Rats; Rats, Sprague-Dawley; Reaction Time; Sciatic Nerve; Spinal Cord; Substance P; Succinimides; Wounds, Nonpenetrating | 1992 |
Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis.
Topics: Adolescent; Adult; Child; Chronic Disease; Dermatitis, Atopic; Female; Humans; Male; Peptide Fragments; Radioimmunoassay; Skin; Substance P; Vasoactive Intestinal Peptide | 1992 |
Changes in peptidergic innervation in chronic pancreatitis.
Topics: Adult; Calcitonin Gene-Related Peptide; Chronic Disease; Female; Humans; Male; Nerve Fibers; Neuropeptide Y; Neuropeptides; Pain; Pancreas; Pancreatitis; Peptide PHI; Substance P; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide | 1992 |
Decreased neuropeptide-converting enzyme activities in cerebrospinal fluid during acute but not chronic phases of collagen induced arthritis in rats.
Topics: Acute Disease; Amino Acid Sequence; Analysis of Variance; Animals; Arthritis, Experimental; Chromatography, High Pressure Liquid; Chronic Disease; Collagen; Cysteine Endopeptidases; Dynorphins; Hemoglobins; Metalloendopeptidases; Molecular Sequence Data; Rats; Rats, Wistar; Regression Analysis; Substance P; Time Factors | 1992 |
The role of substance P and calcitonin gene-related peptide containing nerve fibers in maintaining fungiform taste buds in the rat after a chronic chorda tympani nerve injury.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Chorda Tympani Nerve; Chronic Disease; Female; Immunohistochemistry; Nerve Fibers; Rats; Rats, Inbred Strains; Substance P; Taste Buds | 1991 |
[The effect of substance P on the individual and group behaviors of rhesus monkeys].
Topics: Animals; Behavior, Animal; Blood Pressure; Chronic Disease; Group Processes; Hierarchy, Social; Hypertension; Macaca mulatta; Male; Restraint, Physical; Stress, Psychological; Substance P | 1991 |
[A preliminary study on substance P and vasoactive intestinal polypeptide contents in intestinal mucosa of chronic diarrhea with splenic weakness].
Topics: Adult; Chronic Disease; Diarrhea; Female; Humans; Intestinal Mucosa; Male; Splenic Diseases; Substance P; Vasoactive Intestinal Peptide | 1991 |
Neurones with epileptiform discharge in the central nervous system and chronic pain. Experimental and clinical investigations.
Topics: Animals; Chronic Disease; Cortical Spreading Depression; Electroencephalography; Epilepsy; Evoked Potentials; Humans; Locus Coeruleus; Neurons; Pain; Raphe Nuclei; Rats; Somatosensory Cortex; Substance P; Thalamic Nuclei | 1991 |
Substance P in chronic pain.
Topics: Adrenocorticotropic Hormone; Back Pain; beta-Endorphin; Chronic Disease; Electric Stimulation Therapy; Electrodes, Implanted; Humans; Pain; Spinal Cord; Substance P; Time Factors | 1991 |
Long-term high frequency transcutaneous electrical nerve stimulation (hi-TNS) in chronic pain. Clinical response and effects on CSF-endorphins, monoamine metabolites, substance P-like immunoreactivity (SPLI) and pain measures.
Topics: Adult; Aged; Chronic Disease; Electric Stimulation Therapy; Endorphins; Female; Follow-Up Studies; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Pain; Pain Management; Phenylacetates; Radioimmunoassay; Substance P; Transcutaneous Electric Nerve Stimulation | 1985 |
Possible neurohumoral mechanisms in CNS stimulation for pain suppression.
Topics: Brain; Chronic Disease; Electric Stimulation Therapy; Electrodes, Implanted; Ganglia, Spinal; Humans; Neurotransmitter Agents; Pain; Pain Management; Periaqueductal Gray; Spinal Cord; Substance P | 1985 |
Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide.
Topics: Adult; Bombesin; Chronic Disease; Colon; Constipation; Enkephalin, Methionine; Female; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Middle Aged; Muscle, Smooth; Peptide PHI; Radioimmunoassay; Substance P; Vasoactive Intestinal Peptide | 1988 |
Spinal cord neuropeptides in a case of chronic pain.
Topics: Calcitonin Gene-Related Peptide; Chronic Disease; Humans; Immunohistochemistry; Male; Middle Aged; Neuropeptides; Pain; Spinal Cord; Substance P | 1988 |
Substance P in CSF of patients with chronic pain syndromes.
Topics: Adult; Aged; Chronic Disease; Depression; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pain; Pain, Intractable; Personality Inventory; Substance P; Syndrome | 1988 |
[Changes in the hormone content of the blood during chronic electrical stimulation of the midbrain].
Topics: Animals; Chronic Disease; Electric Stimulation; Hormones; Mesencephalon; Rabbits; Stress, Psychological; Substance P; Time Factors | 1988 |
Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, e
Topics: Adult; Chronic Disease; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Gastric Mucosa; Gastrins; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Intestinal Mucosa; Male; Middle Aged; Motilin; Neurotensin; Pancreatic Polypeptide; Pancreatitis; Secretin; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1988 |
Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation.
Topics: Biopsy; Chronic Disease; Colitis, Ulcerative; Colon; Constipation; Gastrointestinal Transit; Hemorrhoids; Humans; Intestinal Mucosa; Radioimmunoassay; Rectum; Sigmoidoscopy; Substance P | 1989 |